Stockscreener 앱 받기
4.47
3.04%
-0.14
전일 마감가:
$4.61
열려 있는:
$4.61
하루 거래량:
3.02M
Relative Volume:
0.48
시가총액:
$1.34B
수익:
$38.03M
순이익/손실:
$-146.40M
주가수익비율:
-8.5962
EPS:
-0.52
순현금흐름:
$-121.38M
1주 성능:
+5.92%
1개월 성능:
+4.68%
6개월 성능:
+90.21%
1년 성능:
+66.79%
1일 변동 폭
$4.45
$4.6999
1주일 범위
$4.085
$4.6999
52주 변동 폭
$1.8906
$5.82
앱셀레라바이오로직스 Stock (ABCL) Company Profile
명칭
Abcellera Biologics Inc
전화
(604) 559-9005
주소
150 W 4TH AVENUE, VANCOUVER
ABCL을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ABCL
Abcellera Biologics Inc
|
4.47 | 1.28B | 38.03M | -146.40M | -121.38M | -0.52 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
앱셀레라바이오로직스 Stock (ABCL) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-07-07 | 재개 | Leerink Partners | Outperform |
| 2024-08-20 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2024-02-22 | 업그레이드 | The Benchmark Company | Hold → Buy |
| 2023-12-05 | 개시 | KeyBanc Capital Markets | Overweight |
| 2023-11-06 | 다운그레이드 | The Benchmark Company | Buy → Hold |
| 2023-10-13 | 재개 | Piper Sandler | Overweight |
| 2023-02-28 | 개시 | Cowen | Outperform |
| 2022-12-15 | 개시 | Goldman | Buy |
| 2022-11-16 | 개시 | Truist | Buy |
| 2021-12-21 | 개시 | The Benchmark Company | Buy |
| 2021-11-19 | 개시 | Piper Sandler | Overweight |
| 2021-01-05 | 개시 | BMO Capital Markets | Outperform |
| 2021-01-05 | 개시 | Berenberg | Buy |
| 2021-01-05 | 개시 | Credit Suisse | Outperform |
| 2021-01-05 | 개시 | SVB Leerink | Outperform |
| 2021-01-05 | 개시 | Stifel | Buy |
모두보기
앱셀레라바이오로직스 주식(ABCL)의 최신 뉴스
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer - BioSpace
AbCellera Biologics Appoints New Chief Medical Officer - TipRanks
AbCellera appoints Sarah Noonberg as first Chief Medical Officer - Investing.com
AbCellera appoints Sarah Noonberg as Chief Medical Officer - TipRanks
Abcellera appoints Dr. Sarah Noonberg as Chief Medical Officer - MarketScreener
3 Promising Penny Stocks With Market Caps Under $2B - simplywall.st
Bollinger Band Squeeze Points to Volatility in AbCellera Biologics Inc.2025 Market Sentiment & Capital Protection Trading Alerts - beatles.ru
Ichimoku Cloud Indicates Uncertainty Around AbCellera Biologics Inc.2025 Big Picture & Entry Point Confirmation Alerts - beatles.ru
Identifying reversal signals in AbCellera Biologics Inc.Weekly Trade Analysis & Proven Capital Preservation Tips - Newser
Published on: 2025-09-06 12:54:41 - Newser
What the charts say about AbCellera Biologics Inc. todayJuly 2025 Fed Impact & Weekly Setup with ROI Potential - Newser
Will AbCellera Biologics Inc. outperform the marketFed Meeting & Daily Market Momentum Tracking - Newser
Published on: 2025-09-05 14:09:11 - Newser
Is AbCellera Biologics Inc. stock reversal real or fakeJuly 2025 Chart Watch & Free High Return Stock Watch Alerts - Newser
AbCellera at Wells Fargo Conference: Strategic Pipeline Expansion By Investing.com - Investing.com Canada
Can AbCellera Biologics Inc. keep up with sector leadersOptions Play & Weekly Watchlist for Hot Stocks - خودرو بانک
Volume spikes in AbCellera Biologics Inc. stock – what they meanEarnings Beat & High Accuracy Swing Entry Alerts - Newser
How does AbCellera Biologics Inc. score in quality rankingsWeekly Investment Report & Weekly High Return Forecasts - خودرو بانک
Chart overlay techniques for tracking AbCellera Biologics Inc.2025 Historical Comparison & Stock Portfolio Risk Management - Newser
What is AbCellera Biologics Inc. s P E ratio telling usDip Buying & Free Community Consensus Stock Picks - خودرو بانک
Is AbCellera Biologics Inc.’s ROIC above industry average2025 Price Momentum & Weekly Momentum Stock Picks - خودرو بانک
Trend analysis for AbCellera Biologics Inc. this weekJuly 2025 Catalysts & Weekly Breakout Stock Alerts - Newser
Can a trend reversal in AbCellera Biologics Inc. lead to recoveryQuarterly Trade Review & Capital Efficient Trading Techniques - Newser
How to recover losses in AbCellera Biologics Inc. stockJuly 2025 Gainers & Comprehensive Market Scan Reports - Newser
Using economic indicators to assess AbCellera Biologics Inc. potentialAnalyst Downgrade & Free High Return Stock Watch Alerts - Newser
Analyzing drawdowns of AbCellera Biologics Inc. with statistical toolsRisk Management & Reliable Volume Spike Trade Alerts - Newser
Applying Elliott Wave Theory to AbCellera Biologics Inc.July 2025 Rallies & Verified Entry Point Detection - Newser
Applying big data sentiment scoring on AbCellera Biologics Inc.Product Launch & Fast Momentum Entry Tips - Newser
Can machine learning forecast AbCellera Biologics Inc. recoveryJuly 2025 Chart Watch & Low Drawdown Momentum Trade Ideas - Newser
AbCellera Biologics Inc.’s volatility index tracking explainedAnalyst Downgrade & Free High Return Stock Watch Alerts - Newser
Has AbCellera Biologics Inc. formed a bullish divergenceMarket Growth Review & Step-by-Step Trade Execution Guides - Newser
Chart based analysis of AbCellera Biologics Inc. trendsWeekly Gains Report & Community Consensus Trade Alerts - Newser
How to build a dashboard for AbCellera Biologics Inc. stockMarket Activity Report & Low Risk Profit Maximizing Plans - Newser
What indicators show strength in AbCellera Biologics Inc.Trade Performance Summary & AI Optimized Trade Strategies - Newser
Is AbCellera Biologics Inc. affected by consumer sentiment2025 Major Catalysts & Verified Momentum Watchlists - خودرو بانک
Does AbCellera Biologics Inc. have consistent dividend growthWeekly Loss Report & Fast Momentum Stock Entry Tips - خودرو بانک
Is AbCellera Biologics Inc. part of any ETFProduct Launch & AI Based Buy and Sell Signals - خودرو بانک
Is AbCellera Biologics Inc. a momentum stockTrade Risk Report & Fast Entry and Exit Trade Plans - خودرو بانک
Real time scanner hits for AbCellera Biologics Inc. explainedIndex Update & Risk Controlled Swing Trade Alerts - Newser
Opinion: Defence spending must include health spending too - The Globe and Mail
Evaluating AbCellera Biologics Inc. with trendline analysis2025 Technical Patterns & Low Drawdown Investment Ideas - Newser
Breakout Watch: How does AbCellera Biologics Inc. score in quality rankingsWeekly Investment Recap & Risk Managed Investment Strategies - خودرو بانک
Applying chart zones and confluence areas to AbCellera Biologics Inc.Weekly Market Outlook & Intraday High Probability Setup Alerts - Newser
Smart tools for monitoring AbCellera Biologics Inc.’s price actionWeekly Trade Recap & Fast Moving Market Watchlists - Newser
Is AbCellera Biologics Inc. on track to beat earningsIPO Watch & Proven Capital Preservation Methods - خودرو بانک
MACD Cross Could Confirm Trend in AbCellera Biologics Inc. getLinesFromResByArray error: size == 0 - 강소기업뉴스
AbCellera Biologics Inc. stock trend outlook and recovery path2025 Top Gainers & Risk Controlled Daily Trade Plans - Newser
Detecting price anomalies in AbCellera Biologics Inc. with AIMarket Movement Recap & Technical Entry and Exit Tips - Newser
앱셀레라바이오로직스 (ABCL) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.93%
0.10%
자본화:
|
볼륨(24시간):